| Assessment of self-medication of antibiotics in a Jordanian population FA Sawair, ZH Baqain, A Abu Karaky, R Abu Eid Medical Principles and Practice 18 (1), 21-25, 2008 | 173 | 2008 |
| Selective inhibition of regulatory T cells by targeting the PI3K–Akt pathway R Abu-Eid, RN Samara, L Ozbun, MY Abdalla, JA Berzofsky, ... Cancer immunology research 2 (11), 1080-1089, 2014 | 162 | 2014 |
| Mutant KRAS conversion of conventional T cells into regulatory T cells S Zdanov, M Mandapathil, R Abu-Eid, S Adamson-Fadeyi, W Wilson, ... Cancer immunology research 4 (4), 354-365, 2016 | 149 | 2016 |
| Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy S Ahmad, R Abu-Eid, R Shrimali, M Webb, V Verma, A Doroodchi, ... Cancer research 77 (8), 1892-1904, 2017 | 108 | 2017 |
| Raman spectroscopy: current applications in breast cancer diagnosis, challenges and future prospects K Hanna, E Krzoska, A Shaaban, D Muirhead, R Abu-Eid, V Speirs British Journal of Cancer, 2021 | 97 | 2021 |
| Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy M Mkrtichyan, N Chong, R Abu-Eid, A Wallecha, R Singh, J Rothman, ... Journal for immunotherapy of cancer 1 (1), 1-9, 2013 | 83 | 2013 |
| Quantification of the global and local complexity of the epithelial-connective tissue interface of normal, dysplastic, and neoplastic oral mucosae using digital imaging RA Eid, G Landini Pathology, research and practice 199 (7), 475, 2003 | 83 | 2003 |
| Enhanced therapeutic efficacy and memory of tumor-specific CD8 T cells by ex vivo PI3K-δ inhibition R Abu-Eid, S Ahmad, Y Lin, M Webb, Z Berrong, R Shrimali, T Kumai, ... Cancer research 77 (15), 4135-4145, 2017 | 77 | 2017 |
| Age and the architecture of oral mucosa R Abu-Eid, F Sawair, G Landini, T Saku Age 34 (3), 651-658, 2012 | 77 | 2012 |
| Akt1 and-2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survival R Abu Eid, KM Friedman, M Mkrtichyan, A Walens, W King, J Janik, ... Oncoimmunology 4 (5), e1005448, 2015 | 53 | 2015 |
| Old-school chemotherapy in immunotherapeutic combination in cancer, a low-cost drug repurposed R Abu-Eid, GSE Razavi, M Mkrtichyan, J Janik, SN Khleif Cancer immunology research 4 (5), 377-382, 2016 | 51 | 2016 |
| Self–Directed Study and Carving Tooth Models for Learning Tooth Morphology: Perceptions of Students at the University of Aberdeen, Scotland R Abu-Eid, K Ewan, J Foley, Y Oweis, J Jayasinghe Journal of dental education 77 (9), 1147-1153, 2013 | 42 | 2013 |
| Morphometrical differences between pseudo‐epitheliomatous hyperplasia in granular cell tumours and squamous cell carcinomas R Abu‐Eid, G Landini Histopathology 48 (4), 407-416, 2006 | 41 | 2006 |
| Deciphering the role of regulatory CD4 T cells in oral and oropharyngeal cancer: a systematic review C O'Higgins, FJ Ward, R Abu Eid Frontiers in oncology 8, 442, 2018 | 38 | 2018 |
| Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients R Abu-Eid, F Ward Immunology Letters, 2021 | 32 | 2021 |
| Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer OE Rahma, VE Herrin, RA Ibrahim, A Toubaji, S Bernstein, O Dakheel, ... Journal of translational medicine 12, 1-10, 2014 | 32 | 2014 |
| Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors–A systematic review NS Piyarathne, R Rasnayake, R Angammana, P Chandrasekera, ... Expert Review of Molecular Diagnostics 21 (8), 789-807, 2021 | 31 | 2021 |
| Programmed death-1 & its ligands: promising targets for cancer immunotherapy RK Shrimali, JE Janik, R Abu-Eid, M Mkrtichyan, SN Khleif Immunotherapy 7 (7), 777-792, 2015 | 29 | 2015 |
| Oligohydramnios compromises lung cells size and interferes with epithelial–endothelial development T Najrana, LM Ramos, R Abu Eid, J Sanchez‐Esteban Pediatric Pulmonology 52 (6), 746-756, 2017 | 25 | 2017 |
| Antigen-specific antitumor responses induced by OX40 agonist are enhanced by the IDO inhibitor indoximod Z Berrong, M Mkrtichyan, S Ahmad, M Webb, E Mohamed, G Okoev, ... Cancer immunology research 6 (2), 201-208, 2018 | 23 | 2018 |
Gabriel LandiniUniversity of Birmingham, U.K.在 bham.ac.uk 的电子邮件经过验证
